SCHEMBL24475752

SCHEMBL24475752

c1ccc2cc(-c3ccc4cc(-c5ccc6ccc(-c7ccc8ccc9cccnc9c8n7)nc6c5)ccc4n3)ccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.46
RAB9A P51151 6/20 0.46
POLB P06746 1/20 0.46
CYP17A1 P05093 1/20 0.42
CYP19A1 P11511 1/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
KDM4E B2RXH2 5/20 0.41
SMN1; SMN2 Q16637 5/20 0.41
NFKB1 P19838 3/20 0.41
CYP3A4 P08684 3/20 0.41
MAPT P10636 3/20 0.41
LMNA P02545 3/20 0.41
CYP2D6 P10635 2/20 0.41
GMNN O75496 2/20 0.41
TP53 P04637 2/20 0.41
THPO P40225 2/20 0.41
PMP22 Q01453 2/20 0.41
HSP90AA1 P07900 1/20 0.41
MMP2 P08253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24475562 0.97 NPC1 (0.46) NPC1RAB9APOLBCYP17A1CYP19A1
SCHEMBL22282089 0.97 NPC1 (0.46) NPC1RAB9APOLBCYP17A1CYP19A1
SCHEMBL24475576 0.96 CYP17A1 (0.45) NPC1RAB9APOLBCYP17A1CYP19A1
SCHEMBL23016257 0.96 NPC1 (0.50) NPC1RAB9APOLBCYP17A1CYP19A1
SCHEMBL23016156 0.95 NPC1 (0.49) NPC1RAB9APOLBCYP17A1CYP19A1
SCHEMBL24475759 0.95 NPC1 (0.45) NPC1RAB9APOLBCYP17A1CYP19A1
SCHEMBL23016359 0.95 NPC1 (0.51) NPC1RAB9APOLBCYP17A1CYP19A1
SCHEMBL24475588 0.94 NPC1 (0.43) NPC1RAB9APOLBCYP17A1CYP19A1
SCHEMBL22282133 0.94 TOP1 (0.48) NPC1RAB9APOLBCYP17A1CYP19A1
SCHEMBL24475473 0.93 TOP1 (0.46) NPC1RAB9APOLBCYP17A1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220173329-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE LT MATERIALS CO., LTD. (KR) 2022-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220173329-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE OXER1, OCIAD1, OR10J3 NPC1 953/4885RAB9A 2499/4885POLB 3997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.